(19)
(11) EP 4 539 865 A1

(12)

(43) Date of publication:
23.04.2025 Bulletin 2025/17

(21) Application number: 23735808.0

(22) Date of filing: 16.06.2023
(51) International Patent Classification (IPC): 
A61K 35/36(2015.01)
A61P 1/00(2006.01)
A61P 11/00(2006.01)
A61K 35/545(2015.01)
A61P 5/00(2006.01)
A61P 13/12(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 35/36; A61K 35/545; A61P 13/12; A61P 11/00; A61P 5/00; A61P 1/00
(86) International application number:
PCT/GB2023/051590
(87) International publication number:
WO 2023/242595 (21.12.2023 Gazette 2023/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 17.06.2022 GB 202208948

(71) Applicant: Cambridge Enterprise Limited
Cambridge CB2 1TN (GB)

(72) Inventors:
  • GILBERTSON, Richard
    Cambridge Hauser Forum 3 Charles Babbage Road Cambridge CB3 0GT (GB)
  • RAHRMANN, Eric
    Cambridge Hauser Forum 3 Charles Babbage Road Cambridge CB3 0GT (GB)

(74) Representative: Appleyard Lees IP LLP 
15 Clare Road
Halifax HX1 2HY
Halifax HX1 2HY (GB)

   


(54) THERAPEUTICS AND METHODS